1. AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study. (23rd January 2014) Authors: Durez, P.; Pavelka, K.; Lazaro, M.; Garcia Kutzbach, A.; Moots, R.; Amital, H.; Yao, R.; Govoni, M.; Vastesaeger, N.; Weng, H. H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0405 Baseline Predictors of Remission Rates during Golimumab Treatment for Rheumatoid Arthritis in the GO-MORE Study. (10th June 2014) Authors: Durez, P.; Pavelka, K.; Lazaro, M.; Garcia Kutzbach, A.; Moots, R.; Amital, H.; Yao, R.; Huyck, S.; Govoni, M.; Weng, H.H.; Vastesaeger, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0160 Prediction of Remission and Low Disease Activity in Dmard-Refractory Patients with RA Treated with Golimumab. (9th June 2015) Authors: Vastesaeger, N.; Durez, P.; Dasgupta, B.; Combe, B.; Schulze-Koops, H.; Louw, I.; Wollenhaupt, J.; Zerbini, C.A.F.; Beaulieu, A.; Pavelka, K.; Lazaro, M.; Garcia Kutzbach, A.; Moots, R.J.; Amital, H.; Huyck, S.; Fu, B.; Govoni, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗